Or Refractory Large B-cell Lymphoma

• CLINICAL_TRIALS research · 2025-12-03
  Clinical Trial Update: Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL) [Phase 2]

  A phase 2 clinical trial (CORAL) is evaluating loncastuximab tesirine plus rituximab as a bridging therapy before standard CAR-T therapy in …